Back
First Interstate BancSystem Vs. Spyre Therapeutics Industry Stock Comparison
Sell
23
FIBK
First Interstate BancSystem
Last Price:
25.79
Seasonality Move:
-0.23%
Sell
39
SYRE
Spyre Therapeutics
Last Price:
25.33
Seasonality Move:
49.76%
Sell
23
First Interstate BancSystem (FIBK)
is a Sell
Is First Interstate BancSystem a Buy, Sell or Hold?
- The current First Interstate BancSystem [FIBK] share price is $25.78. The Score for FIBK is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
- FIBK is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Spyre Therapeutics (SYRE)
is a Sell
Is Spyre Therapeutics a Buy, Sell or Hold?
- The current Spyre Therapeutics [SYRE] share price is $25.43. The Score for SYRE is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- SYRE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FIBK Stock Price Chart
What is First Interstate BancSystem's stock price today?
-
The First Interstate BancSystem share price today is $25.78
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FIBK is experiencing buying pressure, which is a positive indicator for future bullish movement.
SYRE Stock Price Chart
What is Spyre Therapeutics's stock price today?
-
The Spyre Therapeutics share price today is $25.43
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SYRE is experiencing selling pressure, which indicates risk of future bearish movement.
FIBK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.37 | Sell |
Relative Strength Index (14 RSI): | 43.69 | Sell |
Chaikin Money Flow: | 546458 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (25.79 - 27.51) | Sell |
Bollinger Bands (100): | (25.47 - 27.49) | Sell |
SYRE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.04 | Sell |
Relative Strength Index (14 RSI): | 31.35 | Sell |
Chaikin Money Flow: | -1780910 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (32.05 - 37.75) | Sell |
Bollinger Bands (100): | (27.4 - 39.18) | Sell |
FIBK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 25.78 | Buy |
20-day SMA: | 26.38 | Sell |
50-day SMA: | 26.54 | Sell |
200-day SMA: | 26.43 | Sell |
8-day EMA: | 25.8 | Sell |
20-day EMA: | 26.22 | Sell |
50-day EMA: | 26.51 | Sell |
200-day EMA: | 27.1 | Sell |
SYRE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 33.63 | Sell |
20-day SMA: | 34.16 | Sell |
50-day SMA: | 35.1 | Sell |
200-day SMA: | 24.22 | Buy |
8-day EMA: | 32.34 | Sell |
20-day EMA: | 33.91 | Sell |
50-day EMA: | 34.32 | Sell |
200-day EMA: | 27.18 | Sell |
First Interstate BancSystem Earnings Growth & FIBK Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.05 per share, an increase next quarter of $0.05 per share, a decrease this year of $0.38 per share, and an increase next year of $0.26 per share.
Spyre Therapeutics Earnings Growth & SYRE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.10 per share, an increase this year of $9.41 per share, and an increase next year of $0.45 per share.
First Interstate BancSystem Technical Analysis
Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Spyre Therapeutics Technical Analysis
Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | Jun 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |